INO - Inovio Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INO is currently covered by 5 analysts with an average price target of $21.66. This is a potential upside of $19.4 (858.41%) from yesterday's end of day stock price of $2.26.

Inovio Pharmaceuticals's activity chart (see below) currently has 136 price targets and 129 ratings on display. The stock rating distribution of INO is 44.44% BUY and 55.56% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.46% with an average time for these price targets to be met of 559.53 days.

Highest price target for INO is $5, Lowest price target is $3, average price target is $4.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 14-Aug-2025. First documented stock forecast 18-Jun-2014.

Currently out of the existing stock ratings of INO, 4 are a BUY (44.44%), 5 are a HOLD (55.56%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$3

$0.94 (45.63%)

$3

4 months 1 days ago
(14-Aug-2025)

3/8 (37.5%)

$1.38 (85.19%)

1200

Hold

$5

$2.94 (142.72%)

$5

7 months 1 days ago
(14-May-2025)

13/20 (65%)

$3.12 (165.96%)

417

Buy

$15

7 months 1 days ago
(14-May-2025)

2/5 (40%)

$10.92 (267.65%)

367

Buy

$15

7 months 1 days ago
(14-May-2025)

0/2 (0%)

$10.92 (267.65%)

Buy

9 months 1 days ago
(14-Mar-2025)

1/1 (100%)

$5.13 (74.67%)

67

Show more analysts

Please expand the browser size to see the chart

What is INO (Inovio Pharmaceuticals) average time for price targets to be met?

On average it took 559.53 days on average for the stock forecasts to be realized with a an average price target met ratio 79.46

Which analyst has the current highest performing score on INO (Inovio Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on INO (Inovio Pharmaceuticals)?

Charles Duncan has 14 price targets and 8 ratings on INO

Which analyst is the currently most bullish on INO (Inovio Pharmaceuticals)?

Aydin Huseynov with highest potential upside - $177.94

Which analyst is the currently most reserved on INO (Inovio Pharmaceuticals)?

Jason Kolbert with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?